{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:49:25Z","timestamp":1792442965043,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jinf.2012.02.017","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T19:19:19Z","timestamp":1330975159000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":216,"title":["The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England"],"prefix":"10.1016","volume":"65","author":[{"given":"Albert Jan","family":"van Hoek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline A.","family":"Waight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2012.02.017_bib1","series-title":"The H1N1 swine flu vaccination programme 2009\u20132010 Chief Medical Officer Letter","year":"2009"},{"issue":"12","key":"10.1016\/j.jinf.2012.02.017_bib2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.vaccine.2010.01.002","article-title":"Vaccination against pandemic influenza A\/H1N1v in England: a real-time economic evaluation","volume":"28","author":"Baguelin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2012.02.017_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1017\/S0950268807008436","article-title":"Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999\u20132005","volume":"136","author":"Pebody","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2012.02.017_bib4","unstructured":"Immunisation against infectious disease \u2013 The Green Book. Available from: http:\/\/www.dh.gov.uk\/en\/Publichealth\/Immunisation\/Greenbook\/index.htm [accessed August 25, 2011]."},{"issue":"21","key":"10.1016\/j.jinf.2012.02.017_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"Engl J Med"},{"issue":"15","key":"10.1016\/j.jinf.2012.02.017_bib6","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jinf.2012.02.017_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jinf.2012.02.017_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/ciq207","article-title":"The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?","volume":"52","author":"Musher","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.02.017_bib9","unstructured":"JCVI Agenda and meeting papers. Report from the JCVI pneumococcal sub-committee; 2 February 2011. Available from: http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@ab\/documents\/digitalasset\/dh_125139.pdf [accessed August 25, 2011]."},{"key":"10.1016\/j.jinf.2012.02.017_bib10","unstructured":"JCVI Agenda and meeting papers. Possible costs of wider use of PCV13; 2 February 2011. Available from: http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@ab\/documents\/digitalasset\/dh_125137.pdf [accessed August 25, 2011]."},{"key":"10.1016\/j.jinf.2012.02.017_bib11","unstructured":"Key vaccine information: pneumococcal. Department of Health. Available from: http:\/\/www.dh.gov.uk\/en\/Publichealth\/Immunisation\/Keyvaccineinformation\/DH_103944 [accessed August 25, 2011]."},{"key":"10.1016\/j.jinf.2012.02.017_bib12","unstructured":"PRIMIS+ READ code specification. Available from: http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/documents\/digitalasset\/dh_103940.pdf [accessed August 25, 2011]."},{"key":"10.1016\/j.jinf.2012.02.017_bib13","unstructured":"PRIMIS+ logical query definition. Available from: http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/documents\/digitalasset\/dh_103941.pdf [accessed August 25, 2011]."},{"key":"10.1016\/j.jinf.2012.02.017_bib14","unstructured":"READ codes. Available from: http:\/\/www.connectingforhealth.nhs.uk\/systemsandservices\/data\/uktc\/readcodes [accessed August 25, 2011]."},{"key":"10.1016\/j.jinf.2012.02.017_bib15","unstructured":"Office for National Statistics. Mid year population estimates, England and Wales. Available from: http:\/\/www.statistics.gov.uk\/statbase\/Product.asp?vlnk=15106 [accessed August 25, 2011]."},{"key":"10.1016\/j.jinf.2012.02.017_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jinf.2009.12.008","article-title":"Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996\u20132006","volume":"60","author":"Trotter","year":"2009","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.jinf.2012.02.017_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement four years after pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2012.02.017_bib18","unstructured":"Hospital Episode Statistics, The Health and Social Care Information Centre. Available from: http:\/\/www.hesonline.org.uk [accessed August 25, 2011]."},{"issue":"5","key":"10.1016\/j.jinf.2012.02.017_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000081","article-title":"Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2012.02.017_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2334-8-96","article-title":"Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies","volume":"8","author":"Klemets","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2012.02.017_bib21","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-1510","article-title":"Risks of invasive pneumococcal disease in children with underlying chronic diseases","volume":"122","author":"Hjuler","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2012.02.017_bib22","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2009-2150","article-title":"Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use","volume":"126","author":"Pilishvili","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jinf.2012.02.017_bib23","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in england: a cross-sectional study","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.jinf.2012.02.017_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen","volume":"42","author":"Sj\u00f6str\u00f6m","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.jinf.2012.02.017_bib25","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa044113","article-title":"Asthma as a risk factor for invasive pneumococcal disease","volume":"352","author":"Talbot","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jinf.2012.02.017_bib26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/thx.2009.132670","article-title":"Risk of invasive pneumococcal infections among working age adults with asthma","volume":"65","author":"Klemets","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jinf.2012.02.017_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QAD.0b013e32834dcf27","article-title":"Invasive pneumococcal disease among HIV positive individuals in England and Wales, 2000\u20132009","volume":"26","author":"Yin","year":"2012","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jinf.2012.02.017_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/INF.0b013e3181fab1cf","article-title":"Underlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era","volume":"30","author":"Hsu","year":"2011","journal-title":"Pediatr Infect Dis J"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:16:15Z","timestamp":1759007775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445312000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0163445312000473"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2012.02.017","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2012.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}